Zobrazeno 1 - 10
of 172
pro vyhledávání: '"Christine M, Durand"'
Autor:
Fatima Zaman, Melissa L. Smith, Ashwin Balagopal, Christine M. Durand, Andrew D. Redd, Aaron A. R. Tobian
Publikováno v:
mBio, Vol 15, Iss 8 (2024)
ABSTRACT The presence of the HIV-1 reservoir, a group of immune cells that contain intact, integrated, and replication-competent proviruses, is a major challenge to cure HIV-1. HIV-1 reservoir cells are largely unaffected by the cytopathic effects of
Externí odkaz:
https://doaj.org/article/77c80657813d46bbac0a1ffbd7ae670c
Autor:
Tao Liang, MSPH, Jordan H. Salas, BS, MCR, Mary G. Bowring, MPH, Oyinkan Kusemiju, MPH, Brittany Barnaba, MS, Matthew Wingler, CPTC, Deborah McRann, MBA, Alghidak Salama, MD, MPA, R. Patrick Wood, MD, Allan Massie, PhD, William Werbel, MD, PhD, Aaron A. R. Tobian, MD, PhD, Dorry L. Segev, MD, PhD, Christine M. Durand, MD
Publikováno v:
Transplantation Direct, Vol 10, Iss 6, p e1641 (2024)
Background. The HIV Organ Policy Equity Act legalizes organ procurement from donors with HIV (HIV D+). A prior survey of Organ Procurement Organizations (OPOs) estimated >2000 HIV D+ referrals/year; however, only 30–35 HIV D+/year have had organs p
Externí odkaz:
https://doaj.org/article/02b8172e83554a3c86dd648a15422c05
Autor:
Jessica M. Ruck, MD, Alice L. Zhou, MS, Laura B. Zeiser, ScM, Diane Alejo, BA, Christine M. Durand, MD, Allan B. Massie, PhD, MHS, Dorry L. Segev, MD, PhD, Errol L. Bush, MD, Ahmet Kilic, MD
Publikováno v:
JTCVS Open, Vol 12, Iss , Pp 269-279 (2022)
Objective: Heart transplants (HTs) from hepatitis C virus (HCV)-viremic donors to HCV-seronegative recipients (HCV D+/R–) have good 6-month outcomes, but practice uptake and long-term outcomes overall and among candidates on mechanical circulatory
Externí odkaz:
https://doaj.org/article/4a4a4917707f44b4a00fb876a74e12c2
Autor:
Meghan Elizabeth Sise, David Seth Goldberg, Douglas Earl Schaubel, Robert J. Fontana, Jens J. Kort, Rita R. Alloway, Christine M. Durand, Emily A. Blumberg, E. Steve Woodle, Kenneth E. Sherman, Robert S. Brown, Jr., John J. Friedewald, Niraj M. Desai, Samuel T. Sultan, Josh Levitsky, Meghan D. Lee, Ian A. Strohbehn, J. Richard Landis, Melissa Fernando, Jenna L. Gustafson, Raymond T. Chung, Peter Philip Reese
Publikováno v:
Kidney International Reports, Vol 7, Iss 2, Pp 241-250 (2022)
Introduction: Transplanting kidneys from hepatitis C virus (HCV) viremic donors into HCV-negative patients (HCV D-RNA-positive/R-negative) has evolved from experimental to “standard-of-care” at many centers. Nevertheless, most data derive from si
Externí odkaz:
https://doaj.org/article/b7e97dd8d0c64e328e842013af21b456
Autor:
Sarah E. Benner, Yolanda Eby, Xianming Zhu, Reinaldo E. Fernandez, Eshan U. Patel, Jessica E. Ruff, Feben Habtehyimer, Haley A. Schmidt, Charles S. Kirby, Sarah Hussain, Darin Ostrander, Niraj M. Desai, Sander Florman, Meenakshi M. Rana, Rachel Friedman-Moraco, Marcus R. Pereira, Shikha Mehta, Peter Stock, Alexander Gilbert, Michele I. Morris, Valentina Stosor, Sapna A. Mehta, Catherine B. Small, Karthik Ranganna, Carlos A.Q. Santos, Saima Aslam, Jennifer Husson, Maricar Malinis, Nahel Elias, Emily A. Blumberg, Brianna L. Doby, Allan B. Massie, Melissa L. Smith, Jonah Odim, Thomas C. Quinn, Gregory M. Laird, Robert F. Siliciano, Dorry L. Segev, Andrew D. Redd, Christine M. Durand, Aaron A.R. Tobian
Publikováno v:
JCI Insight, Vol 7, Iss 21 (2022)
The HIV latent viral reservoir (LVR) remains a major challenge in the effort to find a cure for HIV. There is interest in lymphocyte-depleting agents, used in solid organ and bone marrow transplantation to reduce the LVR. This study evaluated the LVR
Externí odkaz:
https://doaj.org/article/09d1623efd834d26a727f8f8faacd04a
Autor:
Shanti Seaman, Diane Brown, Ann Eno, Sile Yu, Allan B. Massie, Aaron A. R. Tobian, Christine M. Durand, Dorry L. Segev, Albert W. Wu, Jeremy Sugarman
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-16 (2021)
Abstract Background Transplantation of HIV-positive (HIV+) donor organs for HIV+ recipients (HIV D+/R+) is now being performed as research in the United States, but raises ethical concerns. While patient-reported outcome measures are increasingly use
Externí odkaz:
https://doaj.org/article/f029282d1d0645fc84c71951bc6ce612
Autor:
Afrah S. Sait, MD, Teresa Po-Yu Chiang, MD, MPH, Kieren A. Marr, MD, MBA, Allan B. Massie, PhD, Willa Cochran, CRNP, Pali Shah, MD, Daniel C. Brennan, MD, Alvin G. Thomas, MS, Seema Mehta Steinke, MD, MS, Nitipong Permpalung, MD, MPH, Shmuel Shoham, MD, Christian Merlo, MD, Tania Jain, MD, Brian Boyarsky, MD, Olga Charnaya, MD, Ahmet Gurakar, MD, Kavita Sharma, MD, Christine M. Durand, MD, William A. Werbel, MD, Chiung-Yu Huang, PhD, Darin Ostrander, PhD, Niraj Desai, MD, Min Young Kim, MD, Sami Alasfar, MD, Evan M. Bloch, MD, PhD, Aaron A.R. Tobian, MD PhD, Jacqueline Garonzik-Wang, MD, PhD, Dorry L. Segev, MD, PhD, Robin K. Avery, MD
Publikováno v:
Transplantation Direct, Vol 8, Iss 1, p e1268 (2022)
Background. Few reports have focused on newer coronavirus disease 2019 (COVID-19) therapies (remdesivir, dexamethasone, and convalescent plasma) in solid organ transplant recipients; concerns had been raised regarding possible adverse impact on allog
Externí odkaz:
https://doaj.org/article/d43f8a7fd91142afa711d1b861dece4a
Autor:
Sarah E. Van Pilsum Rasmussen, BA, Shanti Seaman, BA, Morgan A. Johnson, BS, Karen Vanterpool, PhD, Diane M. Brown, RN, MSA, Aaron A.R. Tobian, MD, Timothy Pruett, MD, Varvara Kirchner, MD, Faith E. Fletcher, PhD, Burke Smith, MD, Sonya Trinh, MD, MPH, Dorry L. Segev, MD, PhD, Christine M. Durand, MD, Jeremy Sugarman, MD, MPH, MA
Publikováno v:
Transplantation Direct, Vol 7, Iss 9, p e745 (2021)
Background. HIV+ donor (HIV D+) to HIV+ recipient (HIV R+) transplantation involves ethical considerations related to safety, consent, stigma, and privacy, which could be better understood through studying patients’ actual experiences. Methods. We
Externí odkaz:
https://doaj.org/article/d6ec4f019734478dabe051829265019f
Autor:
Michael T. Ou, BS, Brian J. Boyarsky, MD, Laura B. Zeiser, ScM, Teresa Po-Yu Chiang, MD, MPH, Jake Ruddy, BS, Sarah E. Van Pilsum Rasmussen, BA, Jennifer Martin, Jennifer St. Clair Russell, PhD, MSEd, MCHES, Christine M. Durand, MD, Robin K. Avery, MD, William A. Werbel, MD, Matthew Cooper, MD, Allan B. Massie, PhD, MHS, Dorry L. Segev, MD, PhD, Jacqueline M. Garonzik-Wang, MD, PhD
Publikováno v:
Transplantation Direct, Vol 7, Iss 7, p e713 (2021)
Background. A widely accepted severe acute respiratory syndrome 2 (SARS-CoV-2) vaccine could protect vulnerable populations, but the willingness of solid organ transplant recipients (SOTRs) to accept a potential vaccine remains unknown. Methods. We c
Externí odkaz:
https://doaj.org/article/849ce0396d6d4005a3cfadbc8e1aa618
Autor:
Alexandra T. Strauss, MD, MIE, Tanveen Ishaque, MBBS, ScM, Sharon Weeks, MD, James P. Hamilton, MD, Cem Simsek, MD, Christine M. Durand, MD, Allan B. Massie, PhD, MHS,, Dorry L. Segev, MD, PhD, Ahmet Gurakar, MD, Jacqueline M. Garonzik-Wang, MD, PhD
Publikováno v:
Transplantation Direct, Vol 7, Iss 4, p e684 (2021)
Background. Despite the revolutionary role of direct-acting antivirals for hepatitis C virus (HCV), the treatment timing for liver transplant candidates remains controversial. We hypothesize that deferring treatment until after liver transplantation
Externí odkaz:
https://doaj.org/article/19069d52cafb4226bbe9d829af634dd2